Immunome discovers antibodies capable of neutralizing multiple variants of SARS-CoV-2, including the South African variant, in pseudovirus tests
GenScript Receives Emergency Use Authorization from the FDA for Use of SARS-CoV-2 cPass (TM) Neutralizing Antibodies in Convalescent Plasma Screening
